ibandronate sodium (Mylan Institutional LLC)
Welcome to the PulseAid listing for the ibandronate sodium drug offered from Mylan Institutional LLC. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional LLC |
| NON-PROPRIETARY NAME: | ibandronate sodium |
| SUBSTANCE NAME: | IBANDRONATE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-09-02 |
| END MARKETING DATE: | 0000-00-00 |
ibandronate sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | ibandronate sodium from Mylan Institutional LLC |
| LABELER NAME: | Mylan Institutional LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3(mg/3mL) |
| START MARKETING DATE: | 2014-09-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 67457-524_b3447504-908f-4b1e-8c8f-27fad11a599d |
| PRODUCT NDC: | 67457-524 |
| APPLICATION NUMBER: | ANDA202671 |
Other IBANDRONATE SODIUM Pharmaceutical Manufacturers / Labelers:
